BCYC compared with KOD: revenue, margins and what each company keeps, and the suppliers and customers both name

BCYCBicycle Therapeutics PLC

Mkt capRevenueRevenue

KODKodiak Sciences Inc.

Mkt capRevenueRevenue

Compare

BCYCBicycle Therapeutics PLC

KODKodiak Sciences Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

BCYC1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±22.5%▼−1.55%×0.07

KOD

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.8%▲+3.43%×0.35

May 8 '26±8.6%▼−6.11%×0.71

= impliedBCYC realized, solidKOD realized, hatchedOne scale, both sides: full bar = 23%× = |realized| ÷ impliedSource: market data

Q1 FY26

±15.0%

▲+12.30%

×0.82

Q3 FY25±19.4%▲+3.39%×0.18

BCYCBicycle Therapeutics PLC

3.65▼−4.34%· post 3.65

Mkt cap$256.5MRevenue$34MQ3 FY26Revenue$73MFY25

KODKodiak Sciences Inc.

100.68▲+0.28%· post 99.34

ClosedOct 30 '26

Mkt cap$6.2BRevenue—Revenue—

Compare

ClosedOct 30 '26

BCYCBicycle Therapeutics PLC

KODKodiak Sciences Inc.

3.65▼−4.34%post 3.65

Price

100.68▲+0.28%post 99.34

$256.5M

Mkt cap

$6.2B

Q3 FY26$34M

Revenue

—

FY25$73M

Revenue

—

BCYC3.65▼−4.34%vsKOD100.68▲+0.28%ClosedOct 30 '26